Envestnet Yodlee (ENV) Announces Collaboration With Snowflake
Envestnet | Yodlee ENV yesterday announced its partnership with cloud-based data platform provider Snowflake through which the company will make its data analytics available on Snowflake Data Marketplace.
The partnership makes a wide range of Envestnet’s data analytics, including investment management and corporate planning insights, easily available to businesses. The move seems to be a part of Envestnet’s efforts to increase availability of its data analytics offerings, streamline the process of their purchase and easily integrate them into financial solutions.
Bill Parsons, group president of Data Analytics, Envestnet | Yodlee, said, "Our team is constantly striving to make integration of our data analytics easier for those who need insights quickly and accurately. Snowflake Data Marketplace allows us to bring our data analytics products and solutions to a key channel that is meeting the need for these types of important services."
Notably, Envestnet’s shares have gained 11.8% over the past three months compared with 8.2% growth of the Zacks S&P 500 composite. The industry has lost 1.8% in the said time frame.
Envestnet, Inc Price
Zacks Rank and Stocks to Consider
Envestnet currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader Zacks Business Services sector includes Equifax Inc. EFX, Cross Country Healthcare CCRN and Charles River Associates CRAI, each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.
The long-term expected earnings per share (three to five years) growth rate for Equifax, Cross Country Healthcare and Charles River is pegged at 14%, 10.5% and 15.5%, respectively.
Time to Invest in Legal Marijuana
If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027.
After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%.
You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.
Click to get this free report
Charles River Associates (CRAI): Free Stock Analysis Report
Equifax, Inc. (EFX): Free Stock Analysis Report
Envestnet, Inc (ENV): Free Stock Analysis Report
Cross Country Healthcare, Inc. (CCRN): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.